Hematologic, biochemical, and cardiopulmonary effects of L-arginine supplementation or phosphodiesterase 5 inhibition in patients with sickle cell disease who are on hydroxyurea therapy (Q37415993)
Jump to navigation
Jump to search
scientific article published on 10 February 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Hematologic, biochemical, and cardiopulmonary effects of L-arginine supplementation or phosphodiesterase 5 inhibition in patients with sickle cell disease who are on hydroxyurea therapy |
scientific article published on 10 February 2008 |
Statements
1 reference
Hematologic, biochemical, and cardiopulmonary effects of L-arginine supplementation or phosphodiesterase 5 inhibition in patients with sickle cell disease who are on hydroxyurea therapy (English)
1 reference
Mark T Gladwin
1 reference
Jane A Little
1 reference
Kristine Partovi Hauser
1 reference
Sabrina E Martyr
1 reference
Amy Harris
1 reference
Irina Maric
1 reference
Claudia R Morris
1 reference
Jung H Suh
1 reference
Oswaldo Castro
1 reference
Roberto Machado
1 reference
10 February 2008
1 reference
1 reference
315-321
1 reference
Identifiers
1 reference
1 reference
1 reference